Mural Oncology plc SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/AMural Oncology plcMURADec 16, 2025

   Ownership stake disclosure by Trium Capital LLP (amended)

   Trium Capital LLP, filed by

2. ROUTINE15-12GMural Oncology plcMURADec 15, 2025

   Deregistration notice

3. ROUTINEEFFECTMural Oncology plcMURADec 9, 2025

   Registration declared effective

4. ROUTINES-8 POSMural Oncology plcMURADec 5, 2025

   S-8 POS filing

5. ROUTINES-8 POSMural Oncology plcMURADec 5, 2025

   S-8 POS filing

6. ROUTINES-8 POSMural Oncology plcMURADec 5, 2025

   S-8 POS filing

7. ROUTINEPOS AMMural Oncology plcMURADec 5, 2025

   POS AM filing

8. ROUTINE4Mural Oncology plcMURADec 5, 2025

   9 insider filings

   Benjamin Hickey, insider filing for MURA

   Show all 9

   • 4Insider filing for MURADec 5, 2025
   • 4Insider filing for MURADec 5, 2025
   • 4Insider filing for MURADec 5, 2025
   • 4Insider filing for MURADec 5, 2025
   • 4Insider filing for MURADec 5, 2025
   • 4Insider filing for MURADec 5, 2025
   • 4Insider filing for MURADec 5, 2025
   • 4Insider filing for MURADec 5, 2025
   • 4Insider filing for MURADec 5, 2025

   Benjamin Hickey, reporting

9. NOTABLE25-NSEMural Oncology plcMURADec 5, 2025

   Delisting notice

   Nasdaq Stock Market LLC, filed by

10. ROUTINE8-KMural Oncology plcMURADec 5, 2025

    Current report

11. ROUTINESCHEDULE 13G/AMural Oncology plcMURANov 13, 2025

    Mural Oncology plc (MURA) filed a Schedule 13G/A, disclosing that Prosight Management, LP now holds a 5.1% stake in the company. This filing indicates a change in significant ownership of the oncology company, which may impact investor sentiment and the stock's performance.

    Prosight Management, LP, filed by

12. ROUTINE144Mural Oncology plcMURANov 10, 2025

    2 Form 144 notices

    Vicki L Goodman, planned sale of MURA shares

    Show all 2

    • 144Planned insider sale of MURA sharesNov 10, 2025
    • 144Planned insider sale of MURA sharesNov 10, 2025

    Vicki L Goodman, reporting

13. ROUTINE4Mural Oncology plcMURANov 10, 2025

    2 insider filings

    Vicki L Goodman, insider filing for MURA

    Show all 2

    • 4Insider filing for MURANov 10, 2025
    • 4Insider filing for MURANov 10, 2025

    Vicki L Goodman, reporting

14. ROUTINESCHEDULE 13G/AMural Oncology plcMURANov 7, 2025

    Ownership stake disclosure by Soleus Capital Master Fund, L.P. (amended)

    Soleus Capital Master Fund, L.P., filed by

15. NOTABLE10-QMural Oncology plcMURANov 6, 2025

    Quarterly report

Older filings on EDGAR